SCHEMBL23095095

SCHEMBL23095095

c1ccc(-c2cc(-c3cccc(-c4cccc(-c5cccnc5)c4)c3)nc(-c3ccc(-c4cccc5ccccc45)cc3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
MAPT P10636 6/20 0.50
HPGD P15428 5/20 0.50
KDM4E B2RXH2 5/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
RAB9A P51151 1/20 0.50
TNF P01375 1/20 0.50
CYP11B1 P15538 2/20 0.48
CYP19A1 P11511 2/20 0.48
CYP17A1 P05093 1/20 0.48
CYP11B2 P19099 1/20 0.48
DHODH Q02127 1/20 0.47
KMO O15229 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
GLA P06280 3/20 0.44
LMNA P02545 1/20 0.44
CYP2C9 P11712 2/20 0.42
TSHR P16473 3/20 0.42
PIK3CA P42336 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17917871 1.00 ALDH1A1 (0.50) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17917888 0.99 DHODH (0.49) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17808146 0.99 DHODH (0.49) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL30296872 0.99 DHODH (0.49) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17808147 0.97 ALDH1A1 (0.50) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL30296922 0.95 ALDH1A1 (0.50) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17808138 0.95 ALDH1A1 (0.50) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL19397481 0.95 ALDH1A1 (0.50) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL19397376 0.95 TNF (0.52) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL19637994 0.95 TNF (0.52) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10950797-B2 Organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2021-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10950797-B2 Organic electroluminescent device SLC29A2, SLC29A1, NUDT1 ALDH1A1 427/4885MAPT 2001/4885HPGD 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.